Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Update Il y a 4 ans
Reference: NCT02439203

Woman and Man

Extract

The purpose of a randomized, double-blind, placebo-controlled, 2-way crossover study is to evaluate the efficacy, safety/tolerability and pharmacokinetics of JM-010 for the treatment of subjects with Parkinson's Disease (PD) with levodopa-induced dyskinesia (LID).


Inclusion criteria

  • Parkinson's disease ,Levodopa Induced Dyskinesia (LID)

Links